Headline: Familial vs. Sporadic Amyotrophic Lateral Sclerosis: Dissecting Clinical, Demographic, and Phenotypic Divergences
Introduction: Amyotrophic lateral sclerosis manifests primarily in two forms: sporadic (SALS), accounting for approximately 90% of all cases, and familial (FALS), representing roughly 10%. Although both forms present with clinically indistinguishable end-stage motor syndromes, careful evaluation of familial history, age of onset, and regional symptom presentation reveals distinct underlying disease architectures.
Demographic and Clinical Divergence:
Gender Ratio: SALS exhibits a male predominance (1.3–1.6:1), whereas FALS presents an even 1:1 male-to-female ratio.
Age of Onset: Familial cases present at a significantly younger mean age (approx. 46 years) compared to sporadic cases (56 to 63 years).
Disease Duration: FALS often shows bimodal survival distributions (<1 year or >5 years), whereas SALS follows a more uniform unimodal course of 3 to 4 years.
Anatomical Onset Variations:
Bulbar features occur in 20% to 30% of familial presentations, whereas lower limb onset is notably common across hereditary cohorts.